This website uses cookies to ensure you have the best experience. Learn more

Top Ten Global Pharmaceutical Companies Essay

1560 words - 7 pages

Market intelligence > Top ten global pharma

Top ten global pharma
Dr Vishal Agrawal, project manager, and Sunehli Jamwal, analyst, from GlobalData, highlight the top ten pharmaceutical companies by 2011 revenue.



Johnson & Johnson


US pharmaceutical giant Pfizer maintained its top position in 2011 with stipulated revenue of $67.4 billion, up by 1% compared with $67.1 billion in 2010. The company’s new marketing strategy, coupled with focused organisational, financial and R&D restructuring efforts, compensated for the losses caused by Lipitor’s patent expiry. The approval of Xalkori for lung cancer, Inlyta and pneumococcal vaccine Prevnar 13 have proved to be a ...view middle of the document...

Also contributing to operational sales growth were Prezista and Velcade. During 2011, J&J obtained several regulatory approvals for additional indications for Xarelto and Remicade (infliximab) and for Nucynta ER, an oral analgesic for moderate to severe chronic pain. The European Commission granted marketing authorisation for Edurant, Zytiga (abiraterone acetate) and Incivo (telaprevir), making J&J even more confident about its 2012 results. The company also announced an agreement with Pharmacyclics to jointly develop and market the BTK inhibitor PCI-32765 for the treatment of cancer.





Novartis reported revenues of $58.6 billion during the fiscal year ending December 2011, 16% up from 2010’s figure. The company’s pharmaceutical division received 15 major regulatory approvals in the US, EU and Japan in 2011, including new indications for: everolimus (Afinitor in the EU and Votubia in the US); breakthrough multiple sclerosis therapy Gilenya in Europe and Japan; Dailies Total 1, a daily disposable contact lens in the EU; and WaveLight EX500 Excimer Laser in the US. It has more than 130 projects in development. Novartis’s diversification strategy resulted in the acquisition of eye care global leader Alcon. The acquisition of oncology laboratory Genoptix strengthened the molecular diagnostics unit, while the purchase of vaccines firm Zhejiang Tianyuan provided Novartis with an expanded presence in the Chinese market. 2011 was the beginning of patent expiry for Diovan in the European and US markets, which amounted to a drop of $4 billion. Novartis plans to offset this by discovering innovative medicines and vaccines, and by offering low-cost, high-quality generics in preventive care and treatment.

Bayer, which is managed by the Bayer Group, operates through three subgroups: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. In the third quarter of 2011, Bayer delivered 5% organic sales growth with higher earnings and improved margins. The first three quarters of 2011 generated $38.06 billion and Bayer’s fourth-quarter consensus estimates are in the range of $12.7 billion, to result in a projected total sales growth of $50.76 billion. Sales in Bayer’s pharmaceutical segment were flat, marking $3.76 billion in the third quarter of 2011; however, the company’s pharmaceutical innovation pipeline delivered exciting clinical results and enjoyed a positive regulatory progress. At the end of 2011, Bayer HealthCare received approval of Xarelto (rivaroxaban) for the prevention of strokes in adult patients with atrial fibrillation and the treatment of deep-vein thrombosis. The company’s late stage pharma pipeline includes 13 phase III products and three potential blockbuster drugs: alpharadin, regorafenib, and VEGF Trap-Eye to be launched in the near future.


WorldPharmaceuticalFrontiers |

Market intelligence > Top ten global pharma

F hoffmann-la roche


merck & co

Other Papers Like Top Ten Global Pharmaceutical Companies

Indian Pharma Essay

1257 words - 6 pages %) * Pfizer (23.6 %) * GSK India (19%) * Piramal Healthcare (18.6 %) * Lupin (18.8 %) For details check out List of Top 10 Pharmaceutical Companies in India Future Prospects The Indian pharmaceuticals market is expected to reach US$ 55 billion in 2020 from US$ 12.6 billion in 2009. This was stated in a report title "India Pharma 2020: Propelling access and acceptance, realising true potential" by McKinsey & Company. In the same

Upjohn Merger Case Analysis

1709 words - 7 pages INTRODUCTION The 1990’s saw a highly fragmented pharmaceutical industry with many competitors. The top ten firms in pharmaceutical sales held 28% market share in mid-1995. The top 50 firms held just over 60 percent. Changes were occurring in the pharmaceutical industry in the 1990’s. With pharmaceutical benefit management (PBM) firms working to reduce costs, pharmaceutical firms held less power. PBMs sought to reduce the number of supplier

India Pharmaceutical Cluster

9670 words - 39 pages pharmaceutical products are heavily concentrated in developed markets (the US alone accounts for 36% of sales25 and the US/Europe/Japan collectively account for over 75% of sales26). The top 10 global markets in 2009 were: the US, Japan, France, Germany, China, Italy, Spain, UK, Brazil, and Canada. The global generic pharmaceutical market was estimated to be worth US$88 billion in 2009 and is forecasted to reach US$130 billion by 2014 27 . In

Impact of Tqm on Indian Pharma Industry-Synopsis

3789 words - 16 pages , pharmaceutical companies build their quality approach around Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), Good Clinical Practices (GCP) and their In- house Standard Operating Procedures (SOPs). Why Quality is important for pharmaceutical companies? – Stringent Regulatory requirements – Competitive market – Global competition – Technological advances – Emergence of generic product 5. OBJECTIVES: The objectives of this

Xyz Pharama

5496 words - 22 pages global sales. Exhibit 1 contains the top twenty pharmaceutical companies ranked by sales. Since the mid-1980s, the pharmaceutical industry has been characterized by large and frequent mergers and acquisitions (see Exhibit 2), which have had a dramatic impact on the pharmaceutical landscape. Nevertheless, each pharmaceutical “giant” only holds a relatively small share of the total drug market. This case is written by Bert De Reyck

Pharmaceutical Industry Case Analysis

1532 words - 7 pages multiple regions of the globe including the United States and how Western pharmaceutical firms have responded to their critics regarding the lack of available drugs for countries in Africa that have been plagued by the disease. There are two sides presented in the case opposing each other, the “Western pharmaceutical companies that had transformed themselves from anonymous, low profit chemical suppliers into high profile, top-performing firmsâ

Stem Cell Research Market to 2017

925 words - 4 pages companies and stem cell research companies are boosting stem cell research and development. Almost 90% of the drugs in clinical trials fail due to factors such as lack of effectiveness and adverse side effects of the drug. Usually animal or tumor cells are being used and this leads to jury-rigged tests. Hence all major pharmaceutical companies are looking forward for new technologies that increase the possibility to launch new therapies in the

Zero From Hero

632 words - 3 pages the National Evangelical Alliance. Recognition Chowdhury was recognized as a Global Business Leader in his country. He had been awarded with various national and international recognitions from various business associations. He was considered as a Commercially Important Person (CIP) in Bangladesh. Chowdhury ventured into a partnership pharmaceutical company with three of his friends in 1958. When asked why the name SQUARE was chosen he

Clash Of The Titans (Merger Of Pfizer & Warner-Lambert)

2990 words - 12 pages new Pfizer should develop a strategy for centralizing and refining the now-separate distribution systems of Pfizer and Warner-Lambert.Pfizer's top management believes that its project $4.7 billion investment in its research and development operation will speed up the process of bringing new, viable drugs to market. Historically, larger research and development operations for pharmaceutical companies have not resulted in a real competitive

Ferrel Marketing St

615 words - 3 pages international cars, take foreign holidays, watch international programmes on television, use international hardware and software. On the supply side, multinational and global corporations are increasing in size and embracing more global power. The top 500 companies in the world now account for 70 per cent of world trade and 80 per cent of international investment. Total sales of multinationals are now in excess of world trade, which gives them a


1361 words - 6 pages Foreign investment opportunities for X X is among top generic pharmaceutical companies in the Europe. X’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. Products are sold in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets. I have done analysis of lately published report and company long

Related Essays

Global Top 100 Specialty Chemicals Companies Market Research Report

1009 words - 5 pages Global Top 100 Specialty Chemicals Companies Market Research Report Did you know? - Anthony Fitzpatrick is President of Corporate Development at Croda International Plc.  - Platform Specialty Products Corporation continually seek opportunities to act as an acquirer and consolidator of specialty chemical businesses on a global basis.  - On October 1, 2015, the H.B. Fuller Company announced that it had appointed the Horn Company

China Pharmaceutical Tablet Testing Equipment Industry By Size, Share, Trends, Growth And Global Forecast To 2019

996 words - 4 pages Pharmaceutical Tablet Testing Equipment industry. The report firstly reviews the basic information of Pharmaceutical Tablet Testing Equipment including its classification, application and manufacturing technology; The report then explores global and China’s top manufacturers of Pharmaceutical Tablet Testing Equipment listing their product specification, capacity, Production value, and market share etc.; The report further analyzes

Medicine Sector In Bangladesh Essay

1017 words - 5 pages Pharmaceutical Sector of Bangladesh The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. Manufacturers produce insulin, hormones, and cancer drugs. This sector provides 97% of the total medicinal requirement of the local market. The industry also exports medicines to global markets, including Europe. Pharmaceutical companies are expanding their business with the aim to expand the export

Esops Project Report

1742 words - 7 pages The sector overview and Major players The Indian Pharmaceutical industry is highly fragmented with about 24,000 players (around 330 in the organised sector). The top ten companies make up for more than a third of the market. The Indian pharma industry (IPM) grew by 16% YoY in 2012 to ` 629 bn. It accounts for about 1.4% of the world's pharma industry in value terms and 10% in volume terms. Besides the domestic market, Indian pharma companies